Programming of metabolic and autoimmune diseases in canine and feline: linkage to the gut microbiome
Microbial Pathogenesis · 2023
DOI: 10.1016/j.micpath.2023.106436 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbial Pathogenesis, 2023. Verfasst von Yun Ji und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Animal Nutrition and Feeding, China Agricultural University, Beijing, 100193, China. Electronic address: jiyun@cau.edu.cn. Hauptthemen laut MEDLINE: Cat Diseases, Gastrointestinal Microbiome, Dog Diseases, Autoimmune Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Agricultural University, National Key Research and Development Program of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Animal Nutrition and Feeding, China Agricultural University, Beijing, 100193, China. Electronic address: jiyun@cau.edu.cn.
- State Key Laboratory of Animal Nutrition and Feeding, China Agricultural University, Beijing, 100193, China.
Förderung
- National Natural Science Foundation of China
- China Agricultural University
- National Key Research and Development Program of China
Zitieren
APA
Ji, Y., Yang, Y., & Wu, Z. (2023). Programming of metabolic and autoimmune diseases in canine and feline: linkage to the gut microbiome. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2023.106436
Vancouver
Ji Y, Yang Y, Wu Z. Programming of metabolic and autoimmune diseases in canine and feline: linkage to the gut microbiome. Microbial Pathogenesis. 2023. doi:10.1016/j.micpath.2023.106436
BibTeX
@article{Ji2023,
author = {Ji, Yun and Yang, Ying and Wu, Zhenlong},
title = {Programming of metabolic and autoimmune diseases in canine and feline: linkage to the gut microbiome},
journal = {Microbial Pathogenesis},
year = {2023},
doi = {10.1016/j.micpath.2023.106436}
}
EUVIMED